Incorporation of the 40-Gene Expression Profile (40-GEP) Test to Improve Treatment Decisions in High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients: Case Series and Algorithm

References

• Hu W, Fang L, Ni R, et al. Changing trends in the disease burden of non-melanoma skin cancer globally from 1990 to 2019 and its predicted level in 25 years. BMC Cancer. 2022;22:836.
   PubMed Web of Science ®Google Scholar
• Ciążyńska M, Kamińska-Winciorek G, Lange D, et al. The incidence and clinical analysis of non-melanoma skin cancer. Sci Rep. 2021;11:4337.
   PubMedGoogle Scholar
• Rogers HW, Weinstock MA, Feldman SR, et al. Incidence estimate of nonmelanoma skin cancer (Keratinocyte carcinomas) in the US Population, 2012. JAMA Dermatol. 2015;151:1081–1086.
   PubMed Web of Science ®Google Scholar
• Lukowiak TM, Aizman L, Perz A, et al. Association of age, sex, race, and geographic region with variation of the ratio of basal cell to cutaneous squamous cell carcinomas in the United States. JAMA Dermatol. 2020;156:1192.
   PubMed Web of Science ®Google Scholar
• Schmults CD, Karia PS, Carter JB, et al. Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study. JAMA Dermatol. 2013;149:541–547.
   PubMed Web of Science ®Google Scholar
• Skin Cancer Foundation: Our New Approach to a Challenging Skin Cancer Statistic [Internet]. Skin cancer found, 2021. Available from: https://www.skincancer.org/blog/our-new-approach-to-A-challenging-skin-cancer-statistic/. Accessed March 28, 2023.
   Google Scholar
• Reynolds KA, Schlessinger DI, Yanes AF, et al. Development of a core outcome set for cutaneous squamous cell carcinoma trials: identification of core domains and outcomes. Br J Dermatol. 2021;184:1113–1122.
   PubMed Web of Science ®Google Scholar
• Blomberg M, He SY, Harwood C, et al. Research gaps in the management and prevention of cutaneous squamous cell carcinoma in organ transplant recipients. Br J Dermatol. 2017;177:1225–1233.
   PubMed Web of Science ®Google Scholar
• Wysong A, Newman JG, Covington KR, et al. Validation of a 40-gene expression profile test to predict metastatic risk in localized high-risk cutaneous squamous cell carcinoma. J Am Acad Dermatol. 2021;84:361–369.
   PubMed Web of Science ®Google Scholar
• Ibrahim SF, Kasprzak JM, Hall MA, et al. Enhanced metastatic risk assessment in cutaneous squamous cell carcinoma with the 40-gene expression profile test. Future Oncol. 2022;18:833–847.
   PubMed Web of Science ®Google Scholar
• Farberg AS, Hall MA, Douglas L, et al. Integrating gene expression profiling into NCCN high-risk cutaneous squamous cell carcinoma management recommendations: impact on patient management. Curr Med Res Opin. 2020;36:1301–1307.
   PubMed Web of Science ®Google Scholar
• Teplitz R, Giselle P, Litchman GH, et al. Impact of gene expression profile testing on the management of squamous cell carcinoma by dermatologists. J Drugs Dermatol. 2019;18:980–984.
   PubMed Web of Science ®Google Scholar
• Arron ST, Blalock TW, Guenther JM, et al. Clinical considerations for integrating gene expression profiling into cutaneous squamous cell carcinoma management. J Drugs Dermatol. 2021;20:5s–s11.
   PubMed Web of Science ®Google Scholar
• Litchman GH, Fitzgerald AL, Kurley SJ, et al. Impact of a prognostic 40-gene expression profiling test on clinical management decisions for high-risk cutaneous squamous cell carcinoma. Curr Med Res Opin. 2020;36:1295–1300.
   PubMed Web of Science ®Google Scholar
• Au JH, Hooper PB, Fitzgerald AL, et al. Clinical utility of the 40-Gene Expression Profile (40-GEP) test for improved patient management decisions and disease-related outcomes when combined with current clinicopathological risk factors for cutaneous Squamous Cell Carcinoma (cSCC): case series. Dermatol Ther. 2022;12:591–597.
   Web of Science ®Google Scholar
• Hooper PB, Farberg AS, Fitzgerald AL, et al. Real-world evidence shows clinicians appropriately use the prognostic 40-Gene Expression Profile (40-GEP) test for high-risk cutaneous Squamous Cell Carcinoma (cSCC) Patients. Cancer Invest. 2022;2022;1–12.
   Google Scholar
• Ruiz ES, Karia PS, Morgan FC, et al. The positive impact of radiologic imaging on high-stage cutaneous squamous cell carcinoma management. J Am Acad Dermatol. 2017;76:217–225.
   PubMed Web of Science ®Google Scholar
• Maher JM, Schmults CD, Murad F, et al. Detection of subclinical disease with baseline and surveillance imaging in high-risk cutaneous squamous cell carcinomas. J Am Acad Dermatol. 2020;82:920–926.
   PubMed Web of Science ®Google Scholar
• Gandhi MR, Panizza B, Kennedy D. Detecting and defining the anatomic extent of large nerve perineural spread of malignancy: comparing “targeted” MRI with the histologic findings following surgery. Head Neck. 2011;33:469–475.
   PubMed Web of Science ®Google Scholar
• Nemzek WR, Hecht S, Gandour-Edwards R, et al. Perineural spread of head and neck tumors: how accurate is MR imaging? AJNR Am J Neuroradiol. 1998;19:701–706.
   PubMed Web of Science ®Google Scholar
• Bondt RBJ, Nelemans PJ, Hofman PAM, et al. Detection of lymph node metastases in head and neck cancer: a meta-analysis comparing US, USgFNAC, CT and MR imaging. Eur J Radiol. 2007;64:266–272.
   PubMed Web of Science ®Google Scholar
• Humphreys TR, Shah K, Wysong A, et al. The role of imaging in the management of patients with nonmelanoma skin cancer. J Am Acad Dermatol. 2017;76:591–607.
   PubMed Web of Science ®Google Scholar
• Costantino A, Canali L, Festa BM, et al. Sentinel lymph node biopsy in high-risk cutaneous squamous cell carcinoma of the head and neck: systematic review and meta-analysis. Head Neck. 2022;44:2288.
   PubMed Web of Science ®Google Scholar
• Ilmonen S, Sollamo E, Juteau S, et al. Sentinel lymph node biopsy in high-risk cutaneous squamous cell carcinoma of the head and neck. J Plast Reconstr Aesthet Surg. 2022;75:210–216.
   PubMed Web of Science ®Google Scholar
• Lyman GH, Giuliano AE, Somerfield MR, et al. American society of clinical oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23:7703–7720.
   PubMed Web of Science ®Google Scholar
• Alam M, Armstrong A, Baum C, et al. Guidelines of care for the management of cutaneous squamous cell carcinoma. J Am Acad Dermatol. 2018;78:560–578.
   PubMed Web of Science ®Google Scholar
• Amin MB, Edge S, Greene F, et al., eds. AJCC Cancer Staging Manual. Eighth ed. New York, NY: Springer International Publishing; 2017.
   Google Scholar
• Jambusaria-Pahlajani A, Kanetsky PA, Karia PS, et al. Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system. JAMA Dermatol. 2013;149:402.
   PubMed Web of Science ®Google Scholar
• Tejera-Vaquerizo A, Cañueto J, Llombart B, et al. Predictive value of sentinel lymph node biopsy in cutaneous squamous cell carcinoma based on the AJCC-8 and Brigham and women’s hospital staging criteria. Dermatol Surg. 2020;46:857–862.
   PubMed Web of Science ®Google Scholar
• Quinn PL, Kim JK, Prasath V, et al. Sentinel lymph node biopsy for head and neck cutaneous squamous cell carcinoma using the Brigham and women’s staging system: a cost analysis. Arch Dermatol Res. 2022;2022:1–8.
   Google Scholar
• National Comprehensive Cancer Network: Squamous cell skin cancer, NCCN guidelines version 2.2022, in NCCN clinical practice guidelines in oncology [Internet]; 2022. Available from: https://www.nccn.org/professionals/physician_gls/pdf/squamous.pdf. Accessed March 28, 2023.
   Google Scholar
• Ruiz ES, Karia PS, Besaw R, et al. Performance of the American joint committee on cancer staging manual, 8th edition vs the Brigham and women’s hospital tumor classification system for cutaneous squamous cell carcinoma. JAMA Dermatol. 2019;155:819.
   PubMed Web of Science ®Google Scholar
• Cañueto J, Burguillo J, Moyano-Bueno D, et al. Comparing the eighth and the seventh editions of the American joint committee on cancer staging system and the Brigham and women’s hospital alternative staging system for cutaneous squamous cell carcinoma: implications for clinical practice. J Am Acad Dermatol. 2019;80:106–113.e2.
   PubMed Web of Science ®Google Scholar
• Likhacheva A, Awan M, Barker CA, et al. Definitive and postoperative radiation therapy for basal and squamous cell cancers of the skin: executive summary of an American society for radiation oncology clinical practice guideline. Pract Radiat Oncol. 2020;10:8–20.
   PubMed Web of Science ®Google Scholar
• Ruiz ES, Kus KJB, Smile TD, et al. Adjuvant radiation following clear margin resection of high T-stage cutaneous squamous cell carcinoma halves the risk of local and locoregional recurrence: a dual center retrospective study. J Am Acad Dermatol. 2022;87(1):87–94.
   PubMed Web of Science ®Google Scholar
• Ibrahim SF, Arron ST, Somani A-K, et al. 25726 prospective adjuvant therapy trial design using a prognostic 40-gene expression profile (40-GEP) test for high-risk cutaneous squamous cell carcinoma (cSCC) and BWH staging-based risk assessment. J Am Acad Dermatol. 2021;85:AB67.
   Web of Science ®Google Scholar
• Koyfman SA, Wysong A, Arron S, et al. Improved risk stratification in an adjuvant radiation therapy (ART) eligible cutaneous squamous cell carcinoma (cSCC) patient population by integration of the 40-gene expression profile prognostic test (40-GEP). J Clin Oncol. 2021;39:e21589–e21589.
   Web of Science ®Google Scholar
• Schmults C, Covington KR, Kurley SJ, et al. Implications of a prognostic 40-gene expression profile (40-GEP) test for high-risk cutaneous squamous cell carcinoma (cSCC) on staging-based risk assessment and adjuvant therapy trial design. J Clin Oncol. 2020;38:e22091–e22091.
   Web of Science ®Google Scholar
• van Lee CB, Roorda BM, Wakkee M, et al. Recurrence rates of cutaneous squamous cell carcinoma of the head and neck after mohs micrographic surgery vs. standard excision: a retrospective cohort study. Br J Dermatol. 2019;181:338–343.
   PubMed Web of Science ®Google Scholar
• Khan K, Mykula R, Kerstein R, et al. A 5-year follow-up study of 633 cutaneous SCC excisions: rates of local recurrence and lymph node metastasis. J Plast Reconstr Aesthet Surg. 2018;71:1153–1158.
   PubMed Web of Science ®Google Scholar
• Tschetter AJ, Campoli MR, Zitelli JA, et al. Long-term clinical outcomes of patients with invasive cutaneous squamous cell carcinoma treated with mohs micrographic surgery: a 5-year, multicenter, prospective cohort study. J Am Acad Dermatol. 2020;82:139–148.
   PubMed Web of Science ®Google Scholar
• Massey PR, Schmults CD, Li SJ, et al. Consensus-based recommendations on the prevention of squamous cell carcinoma in solid organ transplant recipients: a delphi consensus statement. JAMA Dermatol. 2021;157:1219–1226.
   PubMed Web of Science ®Google Scholar
• Elghouche AN, Pflum ZE, Schmalbach CE. Immunosuppression impact on head and neck cutaneous squamous cell carcinoma: a systemic review with meta-analysis. Otolaryngol Head Neck Surg. 2019;160:439–446.
   PubMed Web of Science ®Google Scholar
• Flohil SC, van der Leest RJT, Arends LR, et al. Risk of subsequent cutaneous malignancy in patients with prior keratinocyte carcinoma: a systematic review and meta-analysis. Eur J Cancer. 2013;49:2365–2375.
   PubMed Web of Science ®Google Scholar
• Madani S, Marwaha S, Dusendang JR, et al. Ten-year follow-up of persons with sun-damaged skin associated with subsequent development of cutaneous squamous cell carcinoma. JAMA Dermatol. 2021;157:559–565.
   PubMed Web of Science ®Google Scholar
• Themstrup L, Jemec GE, Lock-Andersen J. Patients highly value routine follow-up of skin cancer and cutaneous melanoma. Dan Med J. 2013;60:A4713.
   PubMed Web of Science ®Google Scholar
• Ahmed K, Siegel JJ, Morgan‐Linnell SK, et al. Attitudes of patients with cutaneous melanoma toward prognostic testing using the 31‐gene expression profile test. Cancer Med. 2022;12:2008–2015.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Chi S, Li C. Identification of potential gene drivers of cutaneous squamous cell carcinoma: analysis of microarray data. Medicine. 2020;99:e22257.
   PubMed Web of Science ®Google Scholar
• Thai AA, Lim AM, Solomon BJ, et al. Biology and treatment advances in cutaneous squamous cell carcinoma. Cancers. 2021;13:5645.
   PubMedGoogle Scholar
• Prezzano JC, Scott GA, Lambert Smith F, et al. Concordance of squamous cell carcinoma histologic grading among dermatopathologists and mohs surgeons. Dermatol Surg. 2021;47:1433–1437.
   PubMed Web of Science ®Google Scholar
• Yanik EL, Pfeiffer RM, Freedman DM, et al. Spectrum of immune-related conditions associated with risk of keratinocyte cancers among elderly adults in the United States. Cancer Epidemiol Biomarkers Prev. 2017;26:998–1007.
   PubMed Web of Science ®Google Scholar
• Farberg AS, Fitzgerald AL, Ibrahim SF, et al. Current methods and caveats to risk factor assessment in Cutaneous Squamous Cell Carcinoma (cSCC): a narrative review. Dermatol Ther. 2022;12:267–284.
   Web of Science ®Google Scholar
• El Saghir NS, Charara RN, Kreidieh FY, et al. Global practice and efficiency of multidisciplinary tumor boards: results of an American society of clinical oncology international survey. J Glob Oncol. 2015;1:57–64.
   PubMedGoogle Scholar
• Kirkwood JM, Krakowski AC, Carter JD, et al. Real-world practice patterns in multidisciplinary squamous cell carcinoma care at community oncology centers. J Clin Oncol. 2022;40:261.
   Web of Science ®Google Scholar
• Scope A, Essat M, Pandor A, et al. Gene expression profiling and expanded immunohistochemistry tests to guide selection of chemotherapy regimens in breast cancer management: a systematic review. Int J Technol Assess Health Care. 2017;33:32–45.
   PubMed Web of Science ®Google Scholar
• Kristiansen G. Markers of clinical utility in the differential diagnosis and prognosis of prostate cancer. Mod Pathol. 2018;31:S143–S155.
   PubMed Web of Science ®Google Scholar
• Berger AC, Davidson RS, Poitras JK, et al. Clinical impact of a 31-gene expression profile test for cutaneous melanoma in 156 prospectively and consecutively tested patients. Curr Med Res Opin. 2016;32:1599–1604.
   PubMed Web of Science ®Google Scholar
• Dillon LD, Gadzia JE, Davidson RS, et al. Prospective, multicenter clinical impact evaluation of a 31-gene expression profile test for management of melanoma patients. SKIN J Cutan Med. 2018;2:111–121.
   Google Scholar